FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. TTAN
5. IONS
6. ROIV
7. ORCL
8. QCOM
9. NVS
10. INTC

Go back to FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu
(NASDAQ: ORGO) Delayed: 1.60 --0 (-0%)
Previous Close $1.60    52 Week High $ 
Open $1.60    52 Week Low $ 
Day High $1.60    P/E N/A 
Day Low $1.60    EPS $ 
Volume 100